3H Bio Co., Ltd.

Silver Sponsor

3H Bio Co., Ltd., founded in 2019, is dedicated to developing innovative therapies for metabolic and cardiovascular diseases. While the company maintains a lean core team of only 10, most of its development work is conducted through established and reputable CROs and CDMOs in the United States, Australia, and South Korea. This model ensures both efficiency and credibility, while providing global partners with confidence in the robustness of our pre-clinical and clinical program. 3HBio is backed by committed investors and is currently advancing with Series B funding to accelerate its pipeline.

For more details, please see our website www.threehbio.com

website